Cholelithiasis: evaluation with CT.
Jerome Barakos(Sutter Health), J Halls(LAC+USC Medical Center), Stewart A. Lapin, P M Colletti, D R Radin, Mark Johnson, Philip W. Ralls(LAC+USC Medical Center), W D Boswell
Cited by 104
Related Papers
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
|Neurology|2009|741
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
|The Lancet Neurology|2010|696
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
|JAMA Neurology|2021|602
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
|The Lancet Neurology|2012|512
Novel symptomatology and changing epidemiology of domoic acid toxicosis in California sea lions ( <i>Zalophus californianus</i> ): an increasing risk to marine mammal health
|Proceedings of the Royal Society B Biological Sciences|2007|207